| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/03/2010 | EP2158904A2 Composition for the Transdermal Delivery of Fentanyl |
| 03/03/2010 | EP2158903A2 Transparent Transdermal Nicotine Delivery Devices |
| 03/03/2010 | EP2158902A1 Ion binding compositions |
| 03/03/2010 | EP2158901A2 Alpha aztreonam lysinate |
| 03/03/2010 | EP2158895A2 Method for energizing human beings |
| 03/03/2010 | EP2158254A1 Poly(organophosphazene) hydrogels for drug delivery, preparation method thereof and use thereof |
| 03/03/2010 | EP2158209A2 Neurosteroid compounds |
| 03/03/2010 | EP2158207A1 Thiazoliopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase |
| 03/03/2010 | EP2158206A1 Substituted furopyrimidines and use thereof |
| 03/03/2010 | EP2158202A1 New compounds 892 |
| 03/03/2010 | EP2158195A1 5- (aminoazacyclyl) -3-sulfonyl-lh- indazoles as 5-hydroxytryptamine- 6 ligands for the treatment of cns disorders |
| 03/03/2010 | EP2158194A2 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 03/03/2010 | EP2158184A2 4,5-dihydro-(1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators |
| 03/03/2010 | EP2158183A2 Ion channel modulators and methods of use |
| 03/03/2010 | EP2158028A2 Apparatus and method for mixing of fluids by producing shear and/or cavitation, and components for such an apparatus |
| 03/03/2010 | EP2157978A2 Mc-1 r, mc-2 r, and mu opioid receptors modulation |
| 03/03/2010 | EP2157977A1 Modulation of intestinal flora of hiv patients |
| 03/03/2010 | EP2157972A1 Methods of treatment using intravenous formulations comprising temozolomide |
| 03/03/2010 | EP2157864A2 Stabilized picoplatin dosage form |
| 03/03/2010 | EP2157859A1 Indazole compounds for activating glucokinase |
| 03/03/2010 | EP2091538B1 4-benzyl-1(2h)-phthalazinones as h1 receptor antagonists |
| 03/03/2010 | EP2081572B1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group |
| 03/03/2010 | EP2018375B1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. |
| 03/03/2010 | EP1957484B1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 03/03/2010 | EP1937639B1 Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4) |
| 03/03/2010 | EP1937261B1 Novel azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/03/2010 | EP1922316B1 Benzimidazole thiophene compounds as plk modulators |
| 03/03/2010 | EP1910360B1 Hiv reverse transcriptase inhibitors |
| 03/03/2010 | EP1888580B1 Pyrido[2,3-d]pyrimidines useful as hcv inhibitors, and methods for the preparation thereof |
| 03/03/2010 | EP1877405B1 Benzisoxazole piperidine compounds and methods of use thereof |
| 03/03/2010 | EP1863827B1 Hydrogels for the controlled release of bioactive materials |
| 03/03/2010 | EP1813289B1 Medicinal composition for treating cancer or diabetes |
| 03/03/2010 | EP1773796B1 Oxopiperidine derivatives, preparation and therapeutic use thereof |
| 03/03/2010 | EP1756270B1 Diagnosis and treatment of myeloid and lymphoid cell cancers with chlorotoxin or a derivative |
| 03/03/2010 | EP1753858B1 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
| 03/03/2010 | EP1753719B1 Substituted pyrrolidine-2-ones |
| 03/03/2010 | EP1749001B1 3-piperidinylisochroman-5-ols as dopamine agonists |
| 03/03/2010 | EP1730166B1 Process for preparing macrocyclic dipeptides which are suitable for the treatment of hepatitis c viral infections |
| 03/03/2010 | EP1698622B1 Treatment for severe aphasia in chronic-stage cerebrovascular disorder |
| 03/03/2010 | EP1675465B1 Improved combination bacteriolytic therapy for the treatment of tumors |
| 03/03/2010 | EP1664056B1 Fused pentacyclic polyethers |
| 03/03/2010 | EP1641456B1 Gaboxadol for treating depression and other affective disorders |
| 03/03/2010 | EP1631295B1 Use of condensed heterocyclic compounds as scce inhibitors for the treatment of skin diseases |
| 03/03/2010 | EP1569656B1 Phosphoantigens for regulating an immune response |
| 03/03/2010 | EP1542969B1 Pyrrolidone derivatives as maob inhibitors |
| 03/03/2010 | EP1519952B1 Use of aspartic proteases in cosmetics and therapeutics |
| 03/03/2010 | EP1505973B1 Combinations for treating multiple myeloma |
| 03/03/2010 | EP1496920B1 Pharmaceutical composition containing an extract from barleria prionitis linn and its process of preparation |
| 03/03/2010 | EP1487790B1 Purified lasofoxifene and a method for purification of racemic lasofoxifene by recrystallization |
| 03/03/2010 | EP1424973B1 Disposal system for transdermal dosage form |
| 03/03/2010 | EP1401421B1 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor |
| 03/03/2010 | EP1389183B1 Sulfonamide derivatives |
| 03/03/2010 | EP1386908B1 Amine derivative with potassium channel regulatory function, its preparation and use |
| 03/03/2010 | EP1107964B1 Isoquinoline derivatives with angiogenesis inhibiting activity |
| 03/03/2010 | EP1100801B1 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 03/03/2010 | EP0852499B1 Therapeutic azide compounds |
| 03/03/2010 | CN101663039A Use of chitosans to increase nail growth rate |
| 03/03/2010 | CN101663038A Anti-tumor composition comprising tissue-accumulating chitosan gel |
| 03/03/2010 | CN101663037A Novel 1,8-naphthyridine compounds |
| 03/03/2010 | CN101663036A Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of cranial traumas |
| 03/03/2010 | CN101663035A Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of motor disorders related to parkinson's disease |
| 03/03/2010 | CN101663034A Therapeutic agent for urinary excretion disorder |
| 03/03/2010 | CN101663033A Triazole derivatives which are smo antagonists |
| 03/03/2010 | CN101663032A Use of fungicides for treating fish mycoses |
| 03/03/2010 | CN101663031A Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same |
| 03/03/2010 | CN101663030A Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance |
| 03/03/2010 | CN101663029A Use of hydroxytyrosol as anti-aging agent |
| 03/03/2010 | CN101663028A Combined effects of topiramate and ondansetron on alcohol consumption |
| 03/03/2010 | CN101659639A Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 03/03/2010 | CN101658528A Application of corn silk polysaccharide on preparation of medicine for curing hyperlipidemia |
| 03/03/2010 | CN101658527A Composition for suppressing target gene expression |
| 03/03/2010 | CN101658526A Veterinary compound enrofloxacin injection and preparation method thereof |
| 03/03/2010 | CN101658525A Medicinal composition for resisting thrombotic diseases, preparation method thereof and application thereof |
| 03/03/2010 | CN101658524A Compound anesthetic for dogs |
| 03/03/2010 | CN101658523A New application of clofazimine for curing tuberculosis |
| 03/03/2010 | CN101658522A Application of tacrine short-chain dimer in preparation of medicament for treating neurodegenerative diseases |
| 03/03/2010 | CN101658521A Paracetamol, pseudoephedrine and chlorphenamine compound sustained release preparation |
| 03/03/2010 | CN101658520A Medicinal composition for treating hyperuricemia |
| 03/03/2010 | CN101658519A Medicinal composition for treating hyperuricemia |
| 03/03/2010 | CN101658518A Application of indirubin for preparing hair culture |
| 03/03/2010 | CN101658517A Application of gamma-mangostin in preparing anti-inflammation and pain-relieving medicament |
| 03/03/2010 | CN101658516A Taxol medicinal compositions and preparation method thereof |
| 03/03/2010 | CN101658515A Disinfectant, method for preparing same and application thereof |
| 03/03/2010 | CN101658514A Disinfection bactericide, manufacturing method thereof and application thereof |
| 03/03/2010 | CN101658513A Use of isoliquiritigenin as medicament for preventing and treating or curing postoperative metastasis and relapse of malignant tumors |
| 03/03/2010 | CN101658486A Hydrous external preparation containing sodium loxoprofen |
| 03/03/2010 | CN100592910C Drop pills of lentinan, and preparation method |
| 03/03/2010 | CN100592909C Dosage form of sodium ibuprofen |
| 03/03/2010 | CN100592908C Pharmaceutical spray formulation comprising a hydro fluor alkane and an acylated cyclodextrin |
| 03/03/2010 | CN100592907C Medication doe treating bronchitis, and preparation method |
| 03/03/2010 | CN100592906C Drop pills of vanillin fine powder and preparation method |
| 03/03/2010 | CN100592905C Pet food composition for skin photoprotection |
| 03/03/2010 | CN100592903C Stabilized natural cannabinoid formulation and preparation method thereof |
| 03/02/2010 | US7671238 Conditions ameliorated by monoamine reuptake including, hot flashes, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromyalgia, nervous system disorders; 3-amino-1-[methyl(phenyl)amino]-1-phenylpropan-2-ol for example |
| 03/02/2010 | US7671212 inhibitor for treating a chemokine mediated disease; cancer, angiogenesis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, pain |
| 03/02/2010 | US7671211 Substrates for thioredoxin reductase |
| 03/02/2010 | US7671199 dual inhibitor of VEGFR and FGFR tyrosine kinases; cancer |
| 03/02/2010 | US7671094 Bupropion hydrobromide and therapeutic applications |
| 03/02/2010 | US7671093 Mixed co-crystals and pharmaceutical compositions comprising the same |
| 03/02/2010 | US7671092 Paclitaxel enhancer compounds |